Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012

Clinical Microbiology and Infection

Volumn 21, Issue 6, 2015, Pages 553-559

  Williams, V ^a   Simor, A E ^a   Kiss, A ^b   McGeer, A ^c   Hirji, Z ^d   Larios, O E ^e   Moore, C ^c   Weiss, K ^f  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d SCARBOROUGH HOSPITAL   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Antibiotic resistance; Carbapenem resistance; Clostridium difficile infection; MRSA; VRE

Indexed keywords

CARBAPENEMASE; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL COLONIZATION; CANADA; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CLOSTRIDIUM DIFFICILE INFECTION; ENTEROBACTERIACEAE INFECTION; ENTEROCOCCAL INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FOLLOW UP; HAND WASHING; HEALTH SURVEY; HIGH RISK PATIENT; HOSPITAL; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; TEACHING HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTIONS; DRUG EFFECTS; ENTEROBACTERIACEAE; FEMALE; GRAM POSITIVE BACTERIUM; HETEROZYGOTE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

CLOSTRIDIUM DIFFICILE; ENTEROBACTERIACEAE; ENTEROCOCCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CANADA; CARRIER STATE; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; FEMALE; GRAM-POSITIVE BACTERIA; HOSPITALS; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84930814482     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.01.024     Document Type: Article

References (27)

1. Simor A.E., Gilbert N.L., Gravel D., Mulvey M.R., Bryce E., Loeb M., et al. Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: national surveillance and changing epidemiology, 1995-2007. Infect Control Hosp Epidemiol 2010, 31:348-356.
2. Gravel D., Miller M., Simor A., Taylor G., Gardam M., McGeer A., et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program study. Clin Infect Dis 2009, 48:568-576.
3. Mataseje L.F., Bryce E., Roscoe D., Boyd D.A., Embree J., Gravel D., et al. Carbapenem-resistant Gram-negative bacilli in Canada, 2009-10: results from the Canadian nosocomial infection surveillance program (CNISP). JAntimicrob Chemother 2012, 67:1359-1367.
4. McCracken M., Wong A., Mitchell R., Gravel D., Conly J., Embil J., et al. Molecular epidemiology of vancomcyin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009. JAntimicrob Chemother 2013, 68:1505-1509.
5. Simor A.E., Williams V., McGeer A., Raboud J., Larios O., Weiss K., et al. Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and of Clostridium difficile infection in Canadian hospitals. Infect Control Hosp Epidemiol 2013, 34:687-693.
6. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
7. Miller B.A., Chen L.F., Sexton D.J., Anderson D.J. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 2011, 32:387-390.
8. Magill S.S., Edwards J.R., Bamberg W., Beldavs Z.G., Dumyati G., Kainer M.A., et al. Multistate point-prevalence survey of healthcare-associated infections. NEngl J Med 2014, 370:1198-1208.
9. Haller S., Eckmanns T., Benzler J., Tolksdorf K., Claus H., Gilsdorf A., et al. Results from the first 12 months of the national surveillance of healthcare-associated outbreaks in Germany, 2011/2012. PLoS One 2014, 9:e98100.
10. Public Health Agency of Canada Healthcare-associated Clostridium difficile infections in Canadian acute-care hospitals-surveillance report, January 1st, 2007 to December 31st, 2012 2014, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa.
11. Jarvis W.R., Schlosser J., Jarvis A.A., Chinn R.Y. National point-prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009, 37:263-270.
12. Health Protection Agency Annual counts and rates of C.difficile 2007, Health Protection Agency, London.
13. Wegner C., Hübner N.O., Gleich S., Thalmaier U., Krüger C.M., Kramer A. One-day point prevalence of emerging bacterial pathogens in a nationwide sample of 62 German hospitals in 2012 and comparison with the results of the one-day point prevalence of 2010. GMS Hyg Infect Control 2013, 8(1). Doc12. http://dx.doi.org/10.3205/dgkh00212.eCollection2013.
14. Dantes R., Mu Y., Belflower R., Aragon D., Dumyati G., Harrison L.H., et al. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 2013, 17:1970-1978.
15. Jarvis W.R., Jarvis A.A., Chinn R.Y. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010. Am J Infect Control 2012, 40:194-200.
16. Dulon M., Haamann F., Peters C., Schablon A., Nienhaus A. MRSA prevalence in European healthcare settings: a review. BMC Infect Dis 2011, 11:138.
17. European Centre for Disease Prevention and Control Antimicrobial resistance surveillance in Europe, 2012 Annual report of the european antimicrobial resistance surveillance network (EARS-Net) 2013, ECDC, Stockholm.
18. Köck R., Becker K., Cookson B., van Gemert-Pijnen J.E., Harbarth S., Kluytmans J., et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 2010, 15. pii=19688.
19. Gastmeier P., Schröder C., Behnke M., Meyer E., Geffers C. Dramatic increase in vancomycin-resistant enterococci in Germany. JAntimicrob Chemother 2014, 69:1660-1664.
20. Ramsey A.M., Zilberberg M.D. Secular trends of hospitalization with vancomycin-resistant Enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol 2009, 30:184-186.
21. Jacob J.T., Klein E., Laxminarayan R., Beldavs Z., Lynfeld R., Kallen A.J., et al. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013, 62:165-170.
22. Magiorakos A.P., Suetens C., Monnet D.L., Gagliotti C., Heuer O.E., EARS-Net Coordination Group, et al. The rise of carbapenem resistance in Europe: just the tip of the iceberg?. Antimicrob Resist Infect Control 2013, 2:6.
23. Nordmann P., Poirel L. The difficult-to-treat spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 2014, 20:821-830.
24. Borg M.A., Hulscher M., Scicluna E.A., Richards J., Azanowsky J.M., Xuereb D., et al. Prevention of methicillin-resistant Staphylococcus aureus bloodstream infections in European hospitals: moving beyond policies. JHosp Infect 2014, 87:203-211.
25. Cooper B.S., Stone S.P., Kibbler C.C., Cookson B.D., Roberts J.A., Medley G.F., et al. Isolation measures in the hospital management of methicillin-resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 2004, 329:533-537.
26. MacKenzie F.M., Bruce J., Struelens M.J., Goossens H., Mollison J., Gould I.M. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals. Clin Microbiol Infect 2007, 13:269-276.
27. Grammatico-Gaillon L., Thiolet J.M., Bernillon P., Coignard B., Khoshnood B., Desenclos J.C. Relationship between the prevalence of methicillin-resistant Staphylococcus aureus infection and indicators of nosocomial infection control measures: a population-based study in French hospitals. Infect Control Hosp Epidemiol 2009, 30:861-869.